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abortions in horses. BUNV includes 27 strains / isolates with ac-
tivity around the world. In the US, Panama, Colombia and Guyana
it is documented the pathogenic potential of BUNV in both ani-
mals and humans because the infection by this virus was found
associated with the production of Central Nervous System dis-
ease, congenital malformations and abortions. In Argentina, two
strains of BUNV have been recovered frommosquitoes, (1) CbaAr-
426 (Cordoba, 1964/1965), and (2) AG83-1746 (Santa Fe, 1981).
Serological surveys have detected high prevalence of BUNV
infection in humans (healthy and undifferentiated febrile syn-
drome and neurological) as well as in domestic and wild life
animals but only febrile diseases have been reported in humans
infected by BUNV. During the autumn of 2013 in of Santa Fe
province, took place the ﬁrst outbreak by BUNV in the country,
during which occurred the death of two horses with neurological
syndrome from which 2 new strains of BUNV (SFCrEq231 and
SFBzEq232) were isolated; later (July, 2013) in the same area
another BUNV strain (SFAbCrEq238) was recovered from the
brain of an equine abortion. Serologic records in cohabiting
horses in Santa Fe province indicate a seroprevalence over 50%
(strain CbaAr-426). Genomic ampliﬁcation and the subsequent
phylogenetic analysis of a 250 bp of segment S the 3 new strains
showed 100% homology between them and 98,9% with the strain
CbaAr426 isolated in Cordoba which although is responsible for
high seroprevalence in domestic and wild life animals has not
been found associated with disease production. Moreover the
phylogenetic analysis of the complete genome of the new strains
with the other strains of BUNV available in Genbank showed a
homology of 99,4 % with strain 86MSP18 (isolated from a human
with febrile syndrome in Panama in 1985) for the Segment S. For
this ﬁnal phylogenetic analysis, the strain CbaAr426 It was not
included because the whole genome sequence is not available.
These ﬁndings highlight the circulation of new strains of BUNV in
Argentina and constitute the ﬁrst evidence of a possible associa-
tion between infection by BUNV and neurological syndrome in
domestic animals for our country. Moreover, these results un-
derline the importance of intensifying the surveillance of BUNV to
determine its likely real impact and to improve differential
diagnosis.
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Equine Protozoal Myeloencephalitis (EPM) is a serious neurologic
disease in equids. Although seroprevalence has been reported to
be high in horses, the actual prevalence of disease has been
estimated between 0.5 to 1%, based on laboratory submission to
the University of Kentucky. However, incidence (number of new
diagnosed cases) of EPM in horses has not been reported. The
purpose of this studywas to determine the incidence and breed of
EPM cases in equids presented to Veterinary Teaching Hospitals
(VTH) in North America and to determine if the incidence of EPM
was decreasing over time. A secondary purpose of the study was
to survey veterinary practitioners to determine if they perceive
that the incidence of EPM is decreasing over time. Equine acces-
sions reported to the Veterinary Medical Data Base (VMDB) from
1990-2014 were used for this study. Medical records from theVMDB (Systematized Nomenclature of Medicine [SNOMED] and
Systematized Nomenclature of Veterinary Diseases and Opera-
tions [SNVDO]) were accessed for overall EPM proportional
morbidity rates (PMR), PMR by database, PMR compared by
breed, and annual PMR from 1990-2014. Also, results of an on-line
survey questionnaire (Zoomerang.com) were summarized. The
on-line survey, containing 12 questions, was completed by equine
practitioners who were members of either the Equine Clinicians
Network (ECN) or the American Association of Equine Practi-
tioners (AAEP) list-serves. There were 2,748 cases of EPM per
312,222 accessions resulting in an overall PMR of 0.88%, among
hospitals reporting to the VMDB during the study period. The
PMR was not signiﬁcantly different between the two databases
(SNOMED and SNOVDO). Proportional diagnoses increased from
0.293% in 1990 to 1.952% in 1997, which was a signiﬁcantly
(P<0.05) higher than the overall PMR (0.88%). Although, there
was a signiﬁcant increase in the PMR of EPM cases from 1995-
1998, there was no evidence of a signiﬁcant temporal increase
over the 24-year study period. The PMRs were signiﬁcantly
(P<0.05) higher in Standardbreds (1.592%), Walking Horses
(1.367%), Thoroughbreds (1.314%), andWarmbloods (1.096%) than
all breeds combined (0.88%). However, the PMRs were signiﬁ-
cantly (P<0.05) lower in Draft breeds (0.518%), Ponies (0.591%),
and Quarter Horses (0.694%), when compared to the PMR for all
breeds. For the survey, there were 221 respondents and 153 (69%)
were from private practice and 68 (31%) were from academia. The
average number of practitioners per practice was 8. Thirty-eight
percent of the equine practitioners perceived that it had not
changed over the previous 2-4 years. Our ﬁndings seem to sug-
gest breed predispositions, with higher PMRs being observed in
Standardbreds, Walking Horses, and Thoroughbreds and lower
PMRs being observed in Draft breeds, ponies and Quarter Horses.
The majority of practitioners surveyed thought that the incidence
of EPM had either not changed or decreased in the previous 2-4
years. Although there was a signiﬁcant increase in EPM case
diagnosed from 1995-1997, it appears from these data that the
overall proportion of EPM cases has essentially not changed over
the past 24 years.
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Latent infections are the cornerstone of EHV-1’s continued suc-
cess. Consequently, EHV-1, unlike equine inﬂuenza and even
strangles (S. equi) is not an infection that can be practically
eradicated from equine populations. Conﬁrmation and contain-
ment of EHV-1 outbreaks is necessary to avoid spread of infection
and to minimise the potential for signiﬁcant impact to the equine
industry frommorewidespread outbreaks, in particular, large and
widely disseminated outbreaks of EHV-1 neurological disease. In
recent years, experience gained through management of EHV-1
neurological disease outbreaks in the United Kingdom (UK) has
led to establishment of protocols to control the spread of disease
and minimise equine industry losses. To that end the Animal
Health Trust, working with the UK equine industry, has proposed
three possible tiers of approach as to how EHV-1 neurological
outbreaks can be practically managed. The three tiers of approach
are referred to as Gold, Silver and Bronze and whilst they are all
based on the same set of principles of Segregation of the popula-
tion, Collection and Testing of samples and Observation of clinical
